nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Amcinonide—ANXA1—stomach cancer	0.00747	0.439	CrCbGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TWIST1—stomach cancer	0.00545	0.0541	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AFP—stomach cancer	0.00368	0.0365	CbGpPWpGaD
Budesonide—Hydrocortisone—ANXA1—stomach cancer	0.00315	0.185	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—RXRB—stomach cancer	0.00287	0.0285	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RORA—stomach cancer	0.00237	0.0235	CbGpPWpGaD
Budesonide—Dexamethasone—ANXA1—stomach cancer	0.00235	0.138	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—RORA—stomach cancer	0.00232	0.023	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—RXRB—stomach cancer	0.00227	0.0225	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AFP—stomach cancer	0.00224	0.0222	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—RXRB—stomach cancer	0.0022	0.0218	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—RARB—stomach cancer	0.00208	0.0206	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—stomach cancer	0.00194	0.0192	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—RORA—stomach cancer	0.00184	0.0182	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.00177	0.0176	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—KLF6—stomach cancer	0.00174	0.0172	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—RORA—stomach cancer	0.00173	0.0171	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MT2A—stomach cancer	0.00173	0.0171	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—RARB—stomach cancer	0.00164	0.0163	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—BMP7—stomach cancer	0.00153	0.0152	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—stomach cancer	0.00146	0.0145	CbGpPWpGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00144	0.0142	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.00134	0.0133	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TWIST1—stomach cancer	0.00132	0.0131	CbGpPWpGaD
Budesonide—Prednisolone—CYP2A6—stomach cancer	0.00126	0.0743	CrCbGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—stomach cancer	0.00124	0.0123	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—stomach cancer	0.00124	0.0123	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PLIN2—stomach cancer	0.00124	0.0123	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—FGG—stomach cancer	0.00118	0.0117	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00115	0.0114	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ZNF559—stomach cancer	0.000985	0.00976	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000962	0.00954	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000926	0.00917	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—stomach cancer	0.00091	0.00902	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—stomach cancer	0.000871	0.00863	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RORA—stomach cancer	0.000868	0.00861	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—stomach cancer	0.000835	0.00828	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—stomach cancer	0.00082	0.00813	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	0.000811	0.00804	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—PPARG—stomach cancer	0.000803	0.00797	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—stomach cancer	0.00078	0.00773	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—AHR—stomach cancer	0.000776	0.00769	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000758	0.00752	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000751	0.00745	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—RORA—stomach cancer	0.00075	0.00744	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ZNF160—stomach cancer	0.000746	0.0074	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—stomach cancer	0.000739	0.00733	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.000733	0.00727	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—SMAD4—stomach cancer	0.000725	0.00719	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2A6—stomach cancer	0.000721	0.0424	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.00069	0.00684	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—stomach cancer	0.000688	0.00682	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000675	0.00669	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—stomach cancer	0.000662	0.0389	CrCbGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000661	0.00655	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—stomach cancer	0.000661	0.00655	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—BMP2—stomach cancer	0.000643	0.00638	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—stomach cancer	0.000643	0.00637	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—stomach cancer	0.000635	0.00629	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—stomach cancer	0.00063	0.00625	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000613	0.00607	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—stomach cancer	0.000612	0.00607	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000582	0.00066	CcSEcCtD
Budesonide—Headache—Irinotecan—stomach cancer	0.000579	0.000656	CcSEcCtD
Budesonide—Insomnia—Docetaxel—stomach cancer	0.000578	0.000655	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—GADD45A—stomach cancer	0.000576	0.00571	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PLAU—stomach cancer	0.000574	0.00569	CbGpPWpGaD
Budesonide—Paraesthesia—Docetaxel—stomach cancer	0.000574	0.00065	CcSEcCtD
Budesonide—Alopecia—Methotrexate—stomach cancer	0.000573	0.000649	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—stomach cancer	0.00057	0.000646	CcSEcCtD
Budesonide—Somnolence—Docetaxel—stomach cancer	0.000568	0.000644	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—stomach cancer	0.000568	0.000644	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—stomach cancer	0.000567	0.000643	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—stomach cancer	0.000564	0.00064	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—stomach cancer	0.000564	0.00064	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000564	0.000639	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—stomach cancer	0.000563	0.000638	CcSEcCtD
Budesonide—Flushing—Epirubicin—stomach cancer	0.000563	0.000638	CcSEcCtD
Budesonide—Vomiting—Fluorouracil—stomach cancer	0.000563	0.000638	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—stomach cancer	0.000563	0.000638	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—stomach cancer	0.000562	0.000638	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—stomach cancer	0.000561	0.000636	CcSEcCtD
Budesonide—Insomnia—Capecitabine—stomach cancer	0.00056	0.000634	CcSEcCtD
Budesonide—Rash—Fluorouracil—stomach cancer	0.000558	0.000633	CcSEcCtD
Budesonide—Dermatitis—Fluorouracil—stomach cancer	0.000558	0.000632	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—stomach cancer	0.000557	0.000632	CcSEcCtD
Budesonide—Paraesthesia—Capecitabine—stomach cancer	0.000556	0.00063	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—stomach cancer	0.000555	0.00063	CcSEcCtD
Budesonide—Headache—Fluorouracil—stomach cancer	0.000555	0.000629	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000554	0.000628	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—stomach cancer	0.000553	0.000627	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—stomach cancer	0.000553	0.000626	CcSEcCtD
Budesonide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000552	0.000625	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—stomach cancer	0.000552	0.000625	CcSEcCtD
Budesonide—Dyspnoea—Capecitabine—stomach cancer	0.000552	0.000625	CcSEcCtD
Budesonide—Fatigue—Docetaxel—stomach cancer	0.000551	0.000625	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—stomach cancer	0.00055	0.000624	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—stomach cancer	0.00055	0.000624	CcSEcCtD
Budesonide—Nausea—Irinotecan—stomach cancer	0.000549	0.000622	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—stomach cancer	0.000548	0.000621	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—stomach cancer	0.000547	0.00062	CcSEcCtD
Budesonide—Constipation—Docetaxel—stomach cancer	0.000546	0.000619	CcSEcCtD
Budesonide—Pain—Docetaxel—stomach cancer	0.000546	0.000619	CcSEcCtD
Budesonide—Back pain—Methotrexate—stomach cancer	0.000546	0.000619	CcSEcCtD
Budesonide—Dyspepsia—Capecitabine—stomach cancer	0.000545	0.000617	CcSEcCtD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000543	0.00539	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—stomach cancer	0.000542	0.0319	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.000541	0.00536	CbGpPWpGaD
Budesonide—Visual impairment—Doxorubicin—stomach cancer	0.000541	0.000613	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—SERPINE1—stomach cancer	0.000538	0.00534	CbGpPWpGaD
Budesonide—Decreased appetite—Capecitabine—stomach cancer	0.000538	0.00061	CcSEcCtD
Budesonide—Alopecia—Epirubicin—stomach cancer	0.000536	0.000608	CcSEcCtD
Budesonide—Prednisone—ALB—stomach cancer	0.000535	0.0315	CrCbGaD
Budesonide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000534	0.000605	CcSEcCtD
Budesonide—Fatigue—Capecitabine—stomach cancer	0.000533	0.000605	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—stomach cancer	0.000533	0.00529	CbGpPWpGaD
Budesonide—Vision blurred—Methotrexate—stomach cancer	0.000532	0.000603	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—stomach cancer	0.000531	0.000602	CcSEcCtD
Budesonide—Constipation—Capecitabine—stomach cancer	0.000529	0.0006	CcSEcCtD
Budesonide—Pain—Capecitabine—stomach cancer	0.000529	0.0006	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—stomach cancer	0.000528	0.000599	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—stomach cancer	0.000527	0.000597	CcSEcCtD
Budesonide—Nausea—Fluorouracil—stomach cancer	0.000526	0.000596	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—stomach cancer	0.000525	0.000595	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—stomach cancer	0.000524	0.000594	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—APC—stomach cancer	0.000523	0.00518	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000522	0.000592	CcSEcCtD
Budesonide—Anaemia—Methotrexate—stomach cancer	0.000522	0.000591	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—stomach cancer	0.000521	0.000591	CcSEcCtD
Budesonide—Flushing—Doxorubicin—stomach cancer	0.000521	0.000591	CcSEcCtD
Budesonide—Flatulence—Epirubicin—stomach cancer	0.00052	0.00059	CcSEcCtD
Budesonide—Tension—Epirubicin—stomach cancer	0.000518	0.000587	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—stomach cancer	0.000517	0.000586	CcSEcCtD
Budesonide—Nervousness—Epirubicin—stomach cancer	0.000513	0.000581	CcSEcCtD
Budesonide—Back pain—Epirubicin—stomach cancer	0.000511	0.000579	CcSEcCtD
Budesonide—Feeling abnormal—Capecitabine—stomach cancer	0.00051	0.000578	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—stomach cancer	0.000509	0.000577	CcSEcCtD
Budesonide—Malaise—Methotrexate—stomach cancer	0.000509	0.000577	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—stomach cancer	0.000508	0.000576	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—stomach cancer	0.000507	0.000575	CcSEcCtD
Budesonide—Vertigo—Methotrexate—stomach cancer	0.000507	0.000575	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.000506	0.00502	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000506	0.000573	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—stomach cancer	0.000506	0.000573	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—stomach cancer	0.000505	0.000573	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—stomach cancer	0.000505	0.000573	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—stomach cancer	0.000498	0.000564	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—stomach cancer	0.000496	0.000562	CcSEcCtD
Budesonide—Cough—Methotrexate—stomach cancer	0.000492	0.000558	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—stomach cancer	0.000492	0.000557	CcSEcCtD
Budesonide—Urticaria—Capecitabine—stomach cancer	0.000491	0.000557	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—stomach cancer	0.00049	0.000555	CcSEcCtD
Budesonide—Abdominal pain—Capecitabine—stomach cancer	0.000489	0.000554	CcSEcCtD
Budesonide—Body temperature increased—Capecitabine—stomach cancer	0.000489	0.000554	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—stomach cancer	0.000489	0.000554	CcSEcCtD
Budesonide—Anaemia—Epirubicin—stomach cancer	0.000488	0.000553	CcSEcCtD
Budesonide—Agitation—Epirubicin—stomach cancer	0.000485	0.00055	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.000483	0.00479	CbGpPWpGaD
Budesonide—Flatulence—Doxorubicin—stomach cancer	0.000481	0.000546	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—stomach cancer	0.00048	0.000545	CcSEcCtD
Budesonide—Chest pain—Methotrexate—stomach cancer	0.00048	0.000545	CcSEcCtD
Budesonide—Myalgia—Methotrexate—stomach cancer	0.00048	0.000545	CcSEcCtD
Budesonide—Tension—Doxorubicin—stomach cancer	0.000479	0.000544	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—stomach cancer	0.000478	0.000542	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000477	0.000541	CcSEcCtD
Budesonide—Malaise—Epirubicin—stomach cancer	0.000476	0.00054	CcSEcCtD
Budesonide—Discomfort—Methotrexate—stomach cancer	0.000475	0.000538	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—stomach cancer	0.000475	0.000538	CcSEcCtD
Budesonide—Vertigo—Epirubicin—stomach cancer	0.000474	0.000538	CcSEcCtD
Budesonide—NR3C1—Gene Expression—ZNF559—stomach cancer	0.000474	0.0047	CbGpPWpGaD
Budesonide—Syncope—Epirubicin—stomach cancer	0.000474	0.000537	CcSEcCtD
Budesonide—Back pain—Doxorubicin—stomach cancer	0.000473	0.000536	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—stomach cancer	0.000471	0.000534	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—stomach cancer	0.00047	0.000533	CcSEcCtD
Budesonide—Palpitations—Epirubicin—stomach cancer	0.000467	0.000529	CcSEcCtD
Budesonide—Confusional state—Methotrexate—stomach cancer	0.000464	0.000526	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—stomach cancer	0.000464	0.000526	CcSEcCtD
Budesonide—Cough—Epirubicin—stomach cancer	0.000461	0.000522	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—stomach cancer	0.000461	0.000522	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—stomach cancer	0.00046	0.000522	CcSEcCtD
Budesonide—Asthenia—Docetaxel—stomach cancer	0.000458	0.00052	CcSEcCtD
Budesonide—Infection—Methotrexate—stomach cancer	0.000458	0.000519	CcSEcCtD
Budesonide—Hypertension—Epirubicin—stomach cancer	0.000456	0.000517	CcSEcCtD
Budesonide—Hypersensitivity—Capecitabine—stomach cancer	0.000456	0.000517	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000453	0.000514	CcSEcCtD
Budesonide—Pruritus—Docetaxel—stomach cancer	0.000452	0.000512	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—stomach cancer	0.000452	0.000512	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—stomach cancer	0.000452	0.000512	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—stomach cancer	0.00045	0.00051	CcSEcCtD
Budesonide—Chest pain—Epirubicin—stomach cancer	0.00045	0.00051	CcSEcCtD
Budesonide—Myalgia—Epirubicin—stomach cancer	0.00045	0.00051	CcSEcCtD
Budesonide—Agitation—Doxorubicin—stomach cancer	0.000449	0.000509	CcSEcCtD
Budesonide—Anxiety—Epirubicin—stomach cancer	0.000448	0.000508	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—stomach cancer	0.000447	0.000507	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000446	0.000506	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—stomach cancer	0.000445	0.000505	CcSEcCtD
Budesonide—Discomfort—Epirubicin—stomach cancer	0.000444	0.000504	CcSEcCtD
Budesonide—Asthenia—Capecitabine—stomach cancer	0.000444	0.000503	CcSEcCtD
Budesonide—Malaise—Doxorubicin—stomach cancer	0.000441	0.0005	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—stomach cancer	0.00044	0.000498	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—stomach cancer	0.000439	0.000498	CcSEcCtD
Budesonide—Anorexia—Methotrexate—stomach cancer	0.000439	0.000498	CcSEcCtD
Budesonide—Syncope—Doxorubicin—stomach cancer	0.000438	0.000497	CcSEcCtD
Budesonide—Pruritus—Capecitabine—stomach cancer	0.000438	0.000496	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—stomach cancer	0.000437	0.000496	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—JUN—stomach cancer	0.000437	0.00433	CbGpPWpGaD
Budesonide—Confusional state—Epirubicin—stomach cancer	0.000435	0.000493	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—stomach cancer	0.000432	0.00049	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—stomach cancer	0.000431	0.000489	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—stomach cancer	0.000429	0.000487	CcSEcCtD
Budesonide—Infection—Epirubicin—stomach cancer	0.000428	0.000485	CcSEcCtD
Budesonide—Cough—Doxorubicin—stomach cancer	0.000426	0.000483	CcSEcCtD
Budesonide—Shock—Epirubicin—stomach cancer	0.000424	0.000481	CcSEcCtD
Budesonide—Diarrhoea—Capecitabine—stomach cancer	0.000423	0.00048	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—stomach cancer	0.000423	0.000479	CcSEcCtD
Budesonide—Dizziness—Docetaxel—stomach cancer	0.000423	0.000479	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—stomach cancer	0.000422	0.000478	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—stomach cancer	0.000421	0.000477	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00042	0.000476	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—stomach cancer	0.000419	0.000475	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—stomach cancer	0.000417	0.000472	CcSEcCtD
Budesonide—Insomnia—Methotrexate—stomach cancer	0.000417	0.000472	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—stomach cancer	0.000416	0.000472	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—stomach cancer	0.000416	0.000472	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—stomach cancer	0.000416	0.000472	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—stomach cancer	0.000415	0.00411	CbGpPWpGaD
Budesonide—Anxiety—Doxorubicin—stomach cancer	0.000415	0.00047	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—stomach cancer	0.000414	0.000469	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—stomach cancer	0.000413	0.0041	CbGpPWpGaD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000413	0.000468	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—stomach cancer	0.000411	0.000466	CcSEcCtD
Budesonide—Anorexia—Epirubicin—stomach cancer	0.000411	0.000466	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—stomach cancer	0.000411	0.000465	CcSEcCtD
Budesonide—Somnolence—Methotrexate—stomach cancer	0.000409	0.000464	CcSEcCtD
Budesonide—Dizziness—Capecitabine—stomach cancer	0.000409	0.000464	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—stomach cancer	0.000407	0.000461	CcSEcCtD
Budesonide—Vomiting—Docetaxel—stomach cancer	0.000406	0.000461	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—stomach cancer	0.000405	0.00046	CcSEcCtD
Budesonide—NR3C1—Gene Expression—PRPF19—stomach cancer	0.000403	0.004	CbGpPWpGaD
Budesonide—Rash—Docetaxel—stomach cancer	0.000403	0.000457	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—stomach cancer	0.000403	0.000456	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—stomach cancer	0.000402	0.000456	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—stomach cancer	0.0004	0.000454	CcSEcCtD
Budesonide—Headache—Docetaxel—stomach cancer	0.0004	0.000454	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.0004	0.00396	CbGpPWpGaD
Budesonide—Anaphylactic shock—Doxorubicin—stomach cancer	0.000399	0.000452	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000398	0.000451	CcSEcCtD
Budesonide—Fatigue—Methotrexate—stomach cancer	0.000397	0.00045	CcSEcCtD
Budesonide—Infection—Doxorubicin—stomach cancer	0.000396	0.000449	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.000395	0.00392	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000394	0.00391	CbGpPWpGaD
Budesonide—Pain—Methotrexate—stomach cancer	0.000394	0.000446	CcSEcCtD
Budesonide—Vomiting—Capecitabine—stomach cancer	0.000393	0.000446	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000393	0.000445	CcSEcCtD
Budesonide—Shock—Doxorubicin—stomach cancer	0.000392	0.000445	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—RXRB—stomach cancer	0.000392	0.00389	CbGpPWpGaD
Budesonide—Nervous system disorder—Doxorubicin—stomach cancer	0.000391	0.000443	CcSEcCtD
Budesonide—Rash—Capecitabine—stomach cancer	0.00039	0.000442	CcSEcCtD
Budesonide—Insomnia—Epirubicin—stomach cancer	0.00039	0.000442	CcSEcCtD
Budesonide—Dermatitis—Capecitabine—stomach cancer	0.00039	0.000442	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—stomach cancer	0.000389	0.000441	CcSEcCtD
Budesonide—Headache—Capecitabine—stomach cancer	0.000388	0.000439	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—stomach cancer	0.000387	0.000439	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—stomach cancer	0.000387	0.000439	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000386	0.000437	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—stomach cancer	0.000384	0.000436	CcSEcCtD
Budesonide—Somnolence—Epirubicin—stomach cancer	0.000383	0.000434	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—stomach cancer	0.00038	0.000431	CcSEcCtD
Budesonide—Nausea—Docetaxel—stomach cancer	0.00038	0.00043	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—stomach cancer	0.00038	0.00043	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.000379	0.00376	CbGpPWpGaD
Budesonide—Dyspepsia—Epirubicin—stomach cancer	0.000379	0.00043	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000377	0.000427	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CXCL8—stomach cancer	0.000376	0.00373	CbGpPWpGaD
Budesonide—Decreased appetite—Epirubicin—stomach cancer	0.000375	0.000425	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000372	0.000422	CcSEcCtD
Budesonide—Fatigue—Epirubicin—stomach cancer	0.000372	0.000421	CcSEcCtD
Budesonide—Pain—Epirubicin—stomach cancer	0.000369	0.000418	CcSEcCtD
Budesonide—Constipation—Epirubicin—stomach cancer	0.000369	0.000418	CcSEcCtD
Budesonide—Nausea—Capecitabine—stomach cancer	0.000367	0.000417	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN1B—stomach cancer	0.000367	0.00364	CbGpPWpGaD
Budesonide—Urticaria—Methotrexate—stomach cancer	0.000366	0.000415	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—stomach cancer	0.000364	0.000413	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—stomach cancer	0.000364	0.000413	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000363	0.000412	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—stomach cancer	0.000362	0.00359	CbGpPWpGaD
Budesonide—Insomnia—Doxorubicin—stomach cancer	0.000361	0.000409	CcSEcCtD
Budesonide—NR3C1—Gene Expression—ZNF160—stomach cancer	0.000359	0.00356	CbGpPWpGaD
Budesonide—Paraesthesia—Doxorubicin—stomach cancer	0.000358	0.000406	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—stomach cancer	0.000356	0.000403	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—stomach cancer	0.000355	0.000403	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—stomach cancer	0.000355	0.000402	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—stomach cancer	0.000352	0.0004	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IRS2—stomach cancer	0.000352	0.00349	CbGpPWpGaD
Budesonide—Dyspepsia—Doxorubicin—stomach cancer	0.000351	0.000398	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—stomach cancer	0.00035	0.00347	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—stomach cancer	0.00035	0.00347	CbGpPWpGaD
Budesonide—Decreased appetite—Doxorubicin—stomach cancer	0.000347	0.000393	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000344	0.00039	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—stomach cancer	0.000344	0.00039	CcSEcCtD
Budesonide—Urticaria—Epirubicin—stomach cancer	0.000342	0.000388	CcSEcCtD
Budesonide—Constipation—Doxorubicin—stomach cancer	0.000341	0.000387	CcSEcCtD
Budesonide—Pain—Doxorubicin—stomach cancer	0.000341	0.000387	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—stomach cancer	0.000341	0.000386	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—stomach cancer	0.000341	0.000386	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—stomach cancer	0.00034	0.00337	CbGpPWpGaD
Budesonide—Hypersensitivity—Methotrexate—stomach cancer	0.000339	0.000385	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—stomach cancer	0.000331	0.00328	CbGpPWpGaD
Budesonide—Asthenia—Methotrexate—stomach cancer	0.00033	0.000375	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—stomach cancer	0.000329	0.000373	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EEF1A2—stomach cancer	0.000329	0.00326	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000326	0.00037	CcSEcCtD
Budesonide—Pruritus—Methotrexate—stomach cancer	0.000326	0.000369	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000324	0.00321	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6ST—stomach cancer	0.000324	0.00321	CbGpPWpGaD
Budesonide—Hypersensitivity—Epirubicin—stomach cancer	0.000318	0.00036	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	0.000317	0.00314	CbGpPWpGaD
Budesonide—Urticaria—Doxorubicin—stomach cancer	0.000317	0.000359	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—stomach cancer	0.000315	0.0185	CrCbGaD
Budesonide—Abdominal pain—Doxorubicin—stomach cancer	0.000315	0.000357	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—stomach cancer	0.000315	0.000357	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—stomach cancer	0.000315	0.000357	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	0.000311	0.00308	CbGpPWpGaD
Budesonide—Asthenia—Epirubicin—stomach cancer	0.000309	0.000351	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	0.000308	0.00305	CbGpPWpGaD
Budesonide—Pruritus—Epirubicin—stomach cancer	0.000305	0.000346	CcSEcCtD
Budesonide—Dizziness—Methotrexate—stomach cancer	0.000305	0.000345	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	0.000302	0.00299	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARG—stomach cancer	0.0003	0.00298	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	0.000299	0.00296	CbGpPWpGaD
Budesonide—Diarrhoea—Epirubicin—stomach cancer	0.000295	0.000334	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—stomach cancer	0.000294	0.000333	CcSEcCtD
Budesonide—Vomiting—Methotrexate—stomach cancer	0.000293	0.000332	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	0.000291	0.00289	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000291	0.00288	CbGpPWpGaD
Budesonide—Rash—Methotrexate—stomach cancer	0.00029	0.000329	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—stomach cancer	0.00029	0.000329	CcSEcCtD
Budesonide—Headache—Methotrexate—stomach cancer	0.000289	0.000327	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—stomach cancer	0.000286	0.000324	CcSEcCtD
Budesonide—Dizziness—Epirubicin—stomach cancer	0.000285	0.000323	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	0.000283	0.00281	CbGpPWpGaD
Budesonide—Pruritus—Doxorubicin—stomach cancer	0.000282	0.00032	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	0.000281	0.00279	CbGpPWpGaD
Budesonide—Vomiting—Epirubicin—stomach cancer	0.000274	0.000311	CcSEcCtD
Budesonide—Nausea—Methotrexate—stomach cancer	0.000274	0.00031	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—stomach cancer	0.000273	0.000309	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HNRNPL—stomach cancer	0.000272	0.0027	CbGpPWpGaD
Budesonide—Rash—Epirubicin—stomach cancer	0.000272	0.000308	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—stomach cancer	0.000271	0.000308	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—SERPINE1—stomach cancer	0.000271	0.00268	CbGpPWpGaD
Budesonide—Headache—Epirubicin—stomach cancer	0.00027	0.000306	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—stomach cancer	0.000264	0.000299	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EEF1A1—stomach cancer	0.00026	0.00257	CbGpPWpGaD
Budesonide—Nausea—Epirubicin—stomach cancer	0.000256	0.00029	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	0.000255	0.00252	CbGpPWpGaD
Budesonide—Vomiting—Doxorubicin—stomach cancer	0.000254	0.000287	CcSEcCtD
Budesonide—Rash—Doxorubicin—stomach cancer	0.000251	0.000285	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—stomach cancer	0.000251	0.000285	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	0.00025	0.00248	CbGpPWpGaD
Budesonide—Headache—Doxorubicin—stomach cancer	0.00025	0.000283	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.00025	0.00248	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	0.000242	0.0024	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—stomach cancer	0.000237	0.000269	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	0.000231	0.00229	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EXOSC5—stomach cancer	0.000224	0.00222	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CPSF1—stomach cancer	0.000224	0.00222	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—POLR3K—stomach cancer	0.000218	0.00216	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	0.000211	0.00209	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CDKN1A—stomach cancer	0.000207	0.00205	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	0.000203	0.00202	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.000198	0.00196	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.00019	0.00188	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RXRB—stomach cancer	0.000189	0.00187	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	0.000186	0.00184	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL13—stomach cancer	0.000185	0.00183	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL18—stomach cancer	0.000185	0.00183	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—stomach cancer	0.000184	0.00183	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000184	0.00183	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000174	0.00173	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS15—stomach cancer	0.000173	0.00171	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS21—stomach cancer	0.000173	0.00171	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000172	0.00171	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SNRPB—stomach cancer	0.00017	0.00168	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000165	0.00164	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.000161	0.00159	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—stomach cancer	0.00016	0.00158	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	0.000158	0.00156	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RORA—stomach cancer	0.000153	0.00151	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT3B—stomach cancer	0.000143	0.00142	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL15—stomach cancer	0.00014	0.00139	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000138	0.00137	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RARB—stomach cancer	0.000136	0.00135	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS26—stomach cancer	0.000131	0.0013	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—stomach cancer	0.000129	0.00128	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000121	0.0012	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000119	0.00118	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPB1—stomach cancer	0.000114	0.00113	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000111	0.0011	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS19—stomach cancer	0.000111	0.0011	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—stomach cancer	0.000111	0.0011	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	0.00011	0.00109	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	0.000109	0.00108	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT1—stomach cancer	0.000106	0.00105	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPA8—stomach cancer	0.000105	0.00104	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACAD8—stomach cancer	0.000104	0.00103	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	9.88e-05	0.000979	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS6—stomach cancer	9.84e-05	0.000975	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GMPR2—stomach cancer	9.25e-05	0.000917	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—IDH3B—stomach cancer	8.46e-05	0.000838	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SUCLG1—stomach cancer	8.46e-05	0.000838	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPP2R1A—stomach cancer	8.17e-05	0.00081	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NDUFV1—stomach cancer	7.86e-05	0.000779	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NDUFS1—stomach cancer	7.86e-05	0.000779	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SMAD4—stomach cancer	7.59e-05	0.000752	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BLVRB—stomach cancer	7.01e-05	0.000695	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGLS—stomach cancer	7.01e-05	0.000695	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ERCC2—stomach cancer	6.93e-05	0.000687	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPAP2A—stomach cancer	6.69e-05	0.000663	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	6.25e-05	0.00062	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA1—stomach cancer	5.96e-05	0.000591	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FBP1—stomach cancer	5.96e-05	0.000591	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NDUFA2—stomach cancer	5.96e-05	0.000591	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CKB—stomach cancer	5.96e-05	0.000591	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLIN2—stomach cancer	5.6e-05	0.000555	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA2—stomach cancer	5.45e-05	0.00054	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NT5E—stomach cancer	5.31e-05	0.000526	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGAM1—stomach cancer	5.31e-05	0.000526	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—stomach cancer	5.28e-05	0.000523	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.07e-05	0.000502	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLCE1—stomach cancer	5.07e-05	0.000502	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UMPS—stomach cancer	4.86e-05	0.000482	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—stomach cancer	4.76e-05	0.000472	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ECHS1—stomach cancer	4.52e-05	0.000448	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PDHA1—stomach cancer	4.52e-05	0.000448	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TYMP—stomach cancer	4.25e-05	0.000421	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FADS1—stomach cancer	4.25e-05	0.000421	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SREBF2—stomach cancer	3.98e-05	0.000394	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RORA—stomach cancer	3.93e-05	0.000389	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDOB—stomach cancer	3.68e-05	0.000365	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX5—stomach cancer	3.42e-05	0.000339	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DPYD—stomach cancer	3.37e-05	0.000334	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—stomach cancer	3.1e-05	0.000307	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—stomach cancer	3.01e-05	0.000298	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—stomach cancer	2.98e-05	0.000295	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.94e-05	0.000292	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.86e-05	0.000284	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO1—stomach cancer	2.79e-05	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD44—stomach cancer	2.47e-05	0.000245	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.1e-05	0.000209	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—stomach cancer	2.06e-05	0.000205	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—stomach cancer	2.04e-05	0.000202	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TYMS—stomach cancer	1.92e-05	0.00019	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—stomach cancer	1.9e-05	0.000188	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ERCC2—stomach cancer	1.78e-05	0.000177	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—stomach cancer	1.68e-05	0.000166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAV1—stomach cancer	1.55e-05	0.000153	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA1—stomach cancer	1.54e-05	0.000153	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—stomach cancer	1.36e-05	0.000135	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—stomach cancer	1.22e-05	0.000121	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—stomach cancer	1.17e-05	0.000116	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—stomach cancer	1.07e-05	0.000106	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—stomach cancer	6.58e-06	6.52e-05	CbGpPWpGaD
